Tema ETFs’s Generate Biomedicines GENB Stock Holding History

Tema ETFs’s Portfolio GENB Stock Details GENB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$305K	Buy	+20,313	New	+$313K	0.01%	490

Other funds holding GENB

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Dynamic Advisor Solutions Phoenix, Arizona $3.52B AUM 15.33% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Tema ETFs's GENB Position: Q3 2026 in Review

Tema ETFs opened a new position in Generate Biomedicines (GENB) in Q3 2026: 20,313 shares worth $305K. The stake represents 0.01% of the portfolio and ranks #490 among its holdings.

6 funds tracked by Wall St. Rank hold GENB as of Q3 2026.

Tema ETFs held 20,313 shares of Generate Biomedicines worth $305K as of Q3 2026.
Generate Biomedicines was a new Tema ETFs position in Q3 2026.
Generate Biomedicines made up 0.01% of Tema ETFs's portfolio in Q3 2026, its #490 holding.
6 funds tracked by Wall St. Rank held Generate Biomedicines as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.